Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats

Life Sciences

Volumn 80, Issue 12, 2007, Pages 1135-1142

  Chaudhry, Jyoti ^a   Ghosh, Narendra Nath ^a   Roy, Kapil ^a   Chandra, Ramesh ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Alloxan induced diabetes; Antioxidants; Kidney; Lipid peroxidation; Liver; Nitric oxide; Oxidative stress; Pancreas; Protein carbonyl

Indexed keywords

5 [4 [2 [(6,7 DIMETHYL 1,2,3,4 TETRAHYDRO 2 OXO 4 QUINOXALINYL)ETHOXY]PHENYL]METHYLENE]THIAZOLIDINE 2,4 DIONE; ALLOXAN; CARBONYL DERIVATIVE; CATALASE; GLITAZONE DERIVATIVE; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; KIDNEY ENZYME; LIPID; LIVER ENZYME; MALONALDEHYDE; NITRIC OXIDE; PANCREAS ENZYME; PIOGLITAZONE; PROTEIN; ROSIGLITAZONE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; EXPERIMENTAL RAT; GLUCOSE BLOOD LEVEL; KIDNEY; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; RAT; STATISTICAL SIGNIFICANCE; TISSUE LEVEL;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYPOGLYCEMIC AGENTS; LIPID PEROXIDES; MALE; MOLECULAR STRUCTURE; NITRIC OXIDE; ORGAN SPECIFICITY; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIAZOLIDINEDIONES;

ANIMALIA; RATTUS;

EID: 33846938515     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.12.004     Document Type: Article

References (41)

1. Al-Azzawie H.F., and Alhamdani M.-S.S. Hypoglycemic and antioxidant effect of oleuropin in alloxan-diabetic rabbits. Life Sciences 78 (2006) 1371-1377
2. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
3. Berlett B.S., and Stadtman E.R. Protein oxidation in aging, disease and oxidative stress. Journal of Biological Chemistry 272 33 (1997) 20313-20316
4. Cantello B.C.C., Cawthrone M.A., Haigh D., Hindley R.M., Smith S.A., and Thurlby P.L. The synthesis of BRL 49653-a novel and potent antihyperglycemic agent. Bioorganic and Medicinal Chemistry Letters 4 (1994) 1181-1184
5. Carlberg I., and Mannerviek B. Glutathione reductase levels in rat brain. Journal of Biological Chemistry 250 (1975) 5475-5480
6. Chang J.-M., Kuo C.-M., Kuo H.-T., Chiu Y.-W., and Chen H.-C. Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy. Journal of Laboratory and Clinical Medicine 146 (2005) 210-215
7. Cohen G., Demeic D., and Marcus J. Measurement of catalase activity in tissue extracts. Analytical Biochemistry 34 (1970) 30-38
8. Desvergne B., and Wahli W. Peroxisome proliferators-activated receptors: nuclear control of metabolism. Endocrine Reviews 20 5 (1999) 649-688
9. Flohé L., and Günzler W. Assays of glutathione peroxidase. In: Packer L. (Ed). Methods in Enzymology 105 (1984), Academic Press 14-120
10. Fujiwara T., Okuno A., Yoshioka S., and Horikoshi H. Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL/KsJ-db/db mice. Metabolism 44 4 (1995) 486-490
11. Gallán P.M., Carrascosa A., Gussinyé M., and Domínguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radical Biology and Medicine 34 12 (2003) 1563-1574
12. Ghosh N.N., Gupta D., Chaudhry J., Chand S., Dass S.K., and Chandra R. Advances in the chemistry of thiazolidinediones as antidiabetic agents. Journal of Indian Chemical Society 80 (2003) 1045-1055
13. Gumieniczek A. Effect of new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits. Life Sciences 74 (2003) 553-562
14. Gupta D., Ghosh N.N., and Chandra R. Synthesis and pharmacological evaluation of substituted 5-[4-2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4-quinoxalinyl)ethoxy]-phenyl]methylene]thiazolidine-2,4-dione derivatives as potent euglycemic and hypolipidemic agents. Bioorganic and Medicinal Chemistry Letters 15 (2005) 1019-1022
15. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione-s-transferase: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 249 (1974) 7130-7139
16. Ho E., and Bray T.M. Antioxidant, NFκB activation and diabetogenesis. Proceedings of Society for Experimental Biology and Medicine 222 (1999) 205-213
17. Hortellano S., Dewez B., and Genaro A.N. Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology 21 (1995) 776-786
18. Hugget A.S.T.G., and Nixon D.A. Use of glucose oxidase,peroxidase, and o-dianisidine in determination of blood and urinary glucose. Lancet 273 (1957) 368-370
19. Jennings P.E., McLaren M., Scott N.A., Saniabadi A.R., and Belch J.J.F. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with nephropathy. Diabetic Medicine 8 (1991) 860-865
20. Jollow D.J., Mitchell J.R., Zampaglione N., and Gillete J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 11 (1974) 151-169
21. Kakkar R., Mantha S.V., Radhi J., Prasad K., and Kalra J. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Journal of Clinical Science 94 6 (1998) 623-632
22. Koracevic D., Koracevic G., Djordjevic V., Andrejevic S., and Cosic V. Method for the measurement of antioxidant activity in human fluids. Journal of Clinical Pathology 54 (2001) 356-361
23. Kowluru R.A. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic stress. Diabetes 52 (2003) 818-823
24. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). Journal of Biological Chemisstry 270 22 (1995) 12953-12956
25. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
26. Lyons T.J. Oxidised low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes?. Diabetic Medicine 8 (1991) 411-419
27. Mahboob M., Rahman M.F., and Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Medicine Journal 46 7 (2005) 322-324
28. Münzel T., Afanas'ev I.B., Kleschyov A.L., and Harrison D.G. Detection of superoxide in vascular tissue. Arteriosclerosis Thrombosis and Vascular Biology 22 (2002) 1761-1768
29. Paoletti F., and Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. In: Packer L., and Glazer A.N. (Eds). Methods in Enzymology 186 (1990), Academic press 209-220
30. Rahman I., and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. European Respiratory Journal 16 (2000) 524-554
31. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. In: Packer L. (Ed). Methods in Enzymology 233 (1994), Academic press 357-363
32. Rolo A.P., and Palmeria C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicology and Applied Pharmacology 212 (2006) 167-178
33. Seif M.A., and Youssef A.A. Evaluation of some biochemical changes in diabetic patients. Clinica Chimica Acta 346 (2004) 161-170
34. Sheu S.-S., Nauduri D., and Anders M.W. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochimica et Biophysica Acta 1762 (2006) 256-265
35. Sohda T., Mizuno K., Tawada H., Sugiyama Y., Fujita T., and Kawamatsu Y. Studies on antidiabetic agents.I. synthesis of 5-[4-(2-methyl-2-phenylpropoxy)benzyl]thiazolidine-2,4-dione (AL-321) and related compounds. Chemical and Pharmaceutical Bulletin 30 10 (1982) 3563-3573
36. Szkudelski T. The mechanism of action of alloxan and streptozotocin in B cells of the rat pancreas. Physiological Research 50 (2001) 536-546
37. Ugochukwu N.H., and Cobourne M.K. Modification of renal oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with extracts from Gongronema latifolium leaves. Clinica Chimica Acta 336 (2003) 73-81
38. Viana M., Aruoma O.I., Herrera E., and Bonet B. Oxidative damage in pregnant diabetic rats and their embryos. Free Radical Biology and Medicine 29 11 (2000) 1115-1121
39. Yadav P., Sarkar S., and Bhatnagar D. Action of Capparis decidua against alloxan-induced oxidative stress and diabetes in rat tissues. Pharmacological Research 36 3 (1997) 221-228
40. Yagi K., Ohkawa H., and Ohishi N. Assay for lipid peroxides in animal tissues by thiobarituric acid reaction. Analytical Biochemistry 95 (1979) 351-358
41. Yoshioka T., Fujita T., Kanai T., Aizawa Y., Kurumada T., Hasegawa K., and Horikoshi H. Studies on hindered phenols and analogues.I. hypolipidemic and hypoglycemic agents with ability to inhibit lipid perxidation. Journal Medicinal Chemistry 32 2 (1989) 421-428